Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Hampshire for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Hampshire only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Hampshire (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Kalyani Govindaraju (NPI 1508952243)

Field	Value
Entity Type	Individual
Organization	Kalyani Govindaraju
Address	10 Prospect St Ste 201
City	Nashua
State	NH
ZIP	03060
Taxonomy	Rheumatology Physician
NPI Enumerated	October 4, 2006

Payer Source	Total Paid
Medicare	$483K
Medicaid	$0

Key Findings

This provider’s Medicare activity is dominated by in-office biologic drug administration and infusion services: the top three revenue codes are J0129 (abatacept), J0897 (denosumab), and J1745 (infliximab), and infusion/chemotherapy administration codes such as 96413 and 96365 also appear in the top codes. The code mix is consistent with a rheumatology practice that delivers biologic injectables and infusions on-site rather than solely managing patients by office visits.

Revenue is highly concentrated in a small number of biologic drug codes: the precomputed top-3 codes account for 82.8% of the provider’s total Medicare revenue, with J0129 contributing $232.1K (48.0% of Medicare revenue), J0897 $103.7K (21.4%), and J1745 $64.5K (13.3%). This concentration indicates the practice’s financial exposure is closely tied to reimbursement for a few high-cost injectable therapies.

Payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $483K and there is no Medicaid billing on file. The absence of Medicaid activity suggests this provider’s Medicare volume is the primary public-payer footprint and any Medicaid business (if present) is negligible or billed under different taxonomies or locations.

Competitive standing on top drugs is modest and varies by molecule: J0129 ranks #741 of 1221 nationally (39th percentile) and is characterized as a typical, unremarkable volume for the code; J0897 ranks #2421 of 10057 (76th percentile) yet is still labeled typical, and J1745 ranks #766 of 1352 (43th percentile) and likewise shows typical, unremarkable volume. These ranks indicate the provider is not a dominant national infusion center for these agents but does participate at meaningful clinical volumes for certain drugs.

There are atypical billing patterns worth noting: J1756 shows 4.3K claims but $0 avg paid/claim and $0 revenue (0.0% of Medicare revenue), and ranks #796 of 868 providers nationally (8th percentile). The combination of a high claim count with no reported Medicare revenue for that drug suggests those administrations are not resulting in Medicare payments and merit follow-up (e.g., bundled billing, payer denials, or other non‑Medicare reimbursement pathways) rather than assuming coding error.

Office evaluation-and-management services are a secondary but visible revenue stream consistent with ongoing outpatient care: 99214 accounts for 327 claims and $28.4K (5.9% of Medicare revenue) while 99215 accounts for 138 claims and $18.4K (3.8%). These E/M volumes indicate the provider maintains an active established-patient panel and combines clinic visits with on-site medication administration.

Infusion and chemotherapy administration codes appear regularly at modest volumes (96413: 130 claims, $13.3K; 96365: 154 claims, $7.5K; 96415 and 96372 also present), supporting an operational model that blends multi-hour infusion sessions with shorter injectable encounters. Together with the drug codes, this pattern is consistent with a practice that schedules both standalone injections and longer infusion appointments rather than exclusively performing brief in-office injections.

The provider’s NPI was enumerated on 2006-10-04 (~20 years ago), signaling an established practice tenure. Given the long enrollment period, the concentrated biologic-revenue profile likely reflects a sustained clinical focus on rheumatology infusion therapies rather than a recent strategic shift.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

17 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	6,830	$30	$232.1K
J0897	Injection, denosumab, 1 mg	5,760	$20	$103.7K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	2,480	$30	$64.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	330	$90	$28.4K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	140	$130	$18.4K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	130	$100	$13.3K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	150	$50	$7.5K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	90	$60	$5.8K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	20	$160	$3.9K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	10	$130	$1.7K

Showing 1–10 of 17

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Hampshire Distribution

Kalyani Govindaraju — 0 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Hampshire

Full comparison — all codes billed, vs. state median

17 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	2	10	7,860	$30	$264.8K
J0897	5	20	2,760	$20	$75.4K
J1745	2	10	1,370	$30	$49.1K
96413	13	20	140	$100	$15.8K
99214	476	3,150	110	$80	$13.2K
99213	1,246	2,900	70	$50	$6.9K
99215	109	1,080	40	$110	$6.8K
99205	220	440	20	$140	$4.9K
99204	1,197	1,340	30	$100	$4.6K
20610	243	250	50	$50	$4.5K

Showing 1–10 of 17

Related Providers

Other providers that share a Tax Identification Number (TIN) with Kalyani Govindaraju, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Foundation Medical Partners Inc	NH	Internal Medicine Physician	$0	$5.8M
Robert Lancaster	MA	Vascular Surgery Physician	$720.8K	$0
Christine Kannler	MA	MOHS-Micrographic Surgery Physician	$526.4K	$0
Julius Tabe	MA	Family Medicine Physician	$449.6K	$2.5K
Mollie Maccormack	NH	MOHS-Micrographic Surgery Physician	$449.5K	$0
Foundation Medical Partners Inc	NH	Addiction (Substance Use Disorder) Counselor	$0	$324.8K
Mandeep Hundal	MA	Pulmonary Disease Physician	$290.7K	$6.6K
David Posnick	NH	Dermatology Physician	$289.5K	$0
Rui Zhang	NH	Rheumatology Physician	$288K	$0
Paul Labinson	NH	Endocrinology, Diabetes & Metabolism Physician	$254.3K	$0

Nearby Providers

Other providers in the same ZIP code as Kalyani Govindaraju, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Community Council Of Nashua Nh, Inc.	NH	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$75.7M
Harbor Homes, Inc.	NH	Federally Qualified Health Center (FQHC)	$0	$23.4M
Southern New Hampshire Medical Center	NH	General Acute Care Hospital	$0	$22.3M
Life Coping Inc.	NH	Case Management Agency	$0	$17.6M
King Healthcare Group LLC	NH	Substance Use Disorder Rehabilitation Clinic/Center	$0	$15.1M
Plus Co. Inc.	NH	Intellectual and/or Developmental Disabilities Residential Treatment Facility	$0	$13.8M
St Joseph Hospital Of Nashua Nh	NH	General Acute Care Hospital	$0	$13M
Alpha Home Care Solutions, Inc	NH	Home Health Agency	$0	$8.4M
Lamprey Health Care Inc	NH	Federally Qualified Health Center (FQHC)	$0	$8.1M
Nashua Center For The Multiply Handicapped, Inc.	NH	In Home Supportive Care Agency	$0	$6.8M

Kalyani Govindaraju — Billing Profile & Reimbursement Data

Sign up for Kalyani Govindaraju — Billing Profile & Reimbursement Data policy alerts

Kalyani Govindaraju — Billing Profile & Reimbursement Data

Sign up for Kalyani Govindaraju — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References